000 | 01950 a2200505 4500 | ||
---|---|---|---|
005 | 20250516153737.0 | ||
264 | 0 | _c20140318 | |
008 | 201403s 0 0 eng d | ||
022 | _a1478-3231 | ||
024 | 7 |
_a10.1111/liv.12216 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aEl Sherrif, Yasser | |
245 | 0 | 0 |
_aHepatotoxicity from anabolic androgenic steroids marketed as dietary supplements: contribution from ATP8B1/ABCB11 mutations? _h[electronic resource] |
260 |
_bLiver international : official journal of the International Association for the Study of the Liver _cSep 2013 |
||
300 |
_a1266-70 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article | ||
650 | 0 | 4 | _aATP Binding Cassette Transporter, Subfamily B, Member 11 |
650 | 0 | 4 |
_aATP-Binding Cassette Transporters _xgenetics |
650 | 0 | 4 |
_aAdenosine Triphosphatases _xgenetics |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAnabolic Agents _xadverse effects |
650 | 0 | 4 |
_aAndrogens _xadverse effects |
650 | 0 | 4 |
_aBiomarkers _xblood |
650 | 0 | 4 |
_aChemical and Drug Induced Liver Injury _xblood |
650 | 0 | 4 |
_aCholestasis, Intrahepatic _xblood |
650 | 0 | 4 | _aDNA Mutational Analysis |
650 | 0 | 4 |
_aDietary Supplements _xadverse effects |
650 | 0 | 4 | _aGenetic Predisposition to Disease |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHyperbilirubinemia _xchemically induced |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 | _aPhenotype |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_agamma-Glutamyltransferase _xblood |
700 | 1 | _aPotts, Jonathan R | |
700 | 1 | _aHoward, Mark R | |
700 | 1 | _aBarnardo, Adrian | |
700 | 1 | _aCairns, Stuart | |
700 | 1 | _aKnisely, Alex S | |
700 | 1 | _aVerma, Sumita | |
773 | 0 |
_tLiver international : official journal of the International Association for the Study of the Liver _gvol. 33 _gno. 8 _gp. 1266-70 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/liv.12216 _zAvailable from publisher's website |
999 |
_c22821754 _d22821754 |